cytarabine has been researched along with Kawasaki Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Can, E; Can, M; Gedikoğlu, G; Savaşan, S; Warrier, I | 1 |
1 other study(ies) available for cytarabine and Kawasaki Disease
| Article | Year |
|---|---|
"Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?".
Topics: Antimetabolites, Antineoplastic; Child, Preschool; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Mucocutaneous Lymph Node Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens | 1998 |